"Southwest General is home to nationally recognized physicians, state-of-the-art technology and a full range of medical, surgical and emergency services, including a Level III trauma center. Our services are designed to provide patients with care that addresses their physical, mental, emotional and spiritual needs."

During the past decade, UH Seidman Cancer Center at Southwest General Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 19 clinical trials were completed, i.e. on average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 18 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UH Seidman Cancer Center at Southwest General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "NRG Oncology" with 14 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UH Seidman Cancer Center at Southwest General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "UH Seidman Cancer Center at Southwest General Hospital" are "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Metastatic Malignant Neoplasm in the Brain" (5 trials), "Stage IIIA Breast Cancer" (5 trials) and "Recurrent Breast Carcinoma" (4 trials). Many other conditions were trialed in "UH Seidman Cancer Center at Southwest General Hospital" in a lesser frequency.

Most popular intervention types in "UH Seidman Cancer Center at Southwest General Hospital" are "Drug" (65 trials), "Other" (46 trials), "Radiation" (31 trials), "Biological" (29 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (21 trials), "Laboratory Biomarker Analysis" (20 trials), "Cisplatin" (12 trials), "Computed Tomography" (12 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "UH Seidman Cancer Center at Southwest General Hospital" are 64 trials for "All" genders, 9 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "UH Seidman Cancer Center at Southwest General Hospital". undefined are not yet recruiting, 27 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UH Seidman Cancer Center at Southwest General Hospital, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UH Seidman Cancer Center at Southwest General Hospital, 0 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".